openPR Logo
Press release

Male Hypogonadism Market 2024: Industry Analysis, Segments, Drivers And Trends To 2033

Male Hypogonadism Market

Male Hypogonadism Market

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Male Hypogonadism Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The male hypogonadism market size has grown strongly in recent years. It will grow from $3.55 billion in 2023 to $3.8 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, awareness and diagnosis, lifestyle factors, chronic illnesses, treatment seeking behavior..

The male hypogonadism market size is expected to see strong growth in the next few years. It will grow to $4.77 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to rising awareness, prevalence of lifestyle-related conditions, innovations in therapies, emphasis on men's health, telemedicine and healthcare accessibility.. Major trends in the forecast period include attention to psychological and sexual health, exploration of nutraceuticals and lifestyle interventions, market expansion in emerging economies, collaborative research initiatives, focus on long-term safety and monitoring..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

Market Segmentation:
The male hypogonadism market covered in this report is segmented -
1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

Major Driver - Rising Infertility Rates Fueled Male Hypogonadism Market Growth
The increase in infertility rates is expected to propel the growth of the male hypogonadism market going forward. Infertility refers to a condition affecting the male or female reproductive system that is characterized by the inability to conceive after 12 months or longer of frequent, unprotected sexual activity. Male hypogonadism, which can lead to decreased sperm production and infertility, is one of the potential causes of male infertility. As a result, the increasing prevalence of male infertility is expected to drive the growth of the male hypogonadism market. For instance, in March 2023, according to the National Institutes of Health (NIH), a US-based Department of Health and Human Services in North America, the estimated male infertility rate is between 4.5% - 6%, while it's 9% in Australia and could be as high as 8% to 12% in Eastern Europe. Also, according to a 2021 study published by the Libyan Journal of Medical Sciences, around 70% of infertility is attributed to male factors in Libya. Therefore, an increase in the infertility rate is driving the growth of the male hypogonadism market.

Competitive Landscape:
Major companies operating in the male hypogonadism market report are Allergan plc, Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, AstraZeneca plc, IBSA Institut Biochimique SA, Juniper Laboratories SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Endocrine Technologies Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Mereo BioPharma Group plc, Myovant Sciences Ltd., Novartis AG, Novo Nordisk A/S, Repros Therapeutics Inc., Sandoz International GmbH, Sanofi SA, Sermonix Pharmaceuticals LLC, Shionogi & Co. Ltd., Solvay SA, TherapeuticsMD Inc., Viking Therapeutics Inc. .

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

Top Trend - Product Innovations Enhance The Male Hypogonadism Market
Product innovations are a key trend gaining popularity in the male hypogonadism market. Companies operating in the male hypogonadism market are innovating new products to sustain their position in the market. For instance, in June 2022, Halozyme, a US-based biotechnology company, launched Tlando, an oral treatment for testosterone replacement therapy of male hypogonadism. Tlando is a prescription drug that contains testosterone, and it is the first oral testosterone treatment approved by FDA. It is used to treat adult men who, as a result of certain medical disorders, have low or no testosterone.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Male Hypogonadism Market Characteristics
3. Male Hypogonadism Market Trends And Strategies
4. Male Hypogonadism Market - Macro Economic Scenario
5. Male Hypogonadism Market Size And Growth
…..
27. Male Hypogonadism Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Male Hypogonadism Market 2024: Industry Analysis, Segments, Drivers And Trends To 2033 here

News-ID: 3404414 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Male

Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism refers to a medical condition in which the male body is unable to produce adequate levels of testosterone, the hormone responsible for the development and maintenance of male sexual characteristics. This condition can have a significant impact on a man's physical and emotional health, including reduced muscle mass, decreased bone density, and decreased The male hypogonadism market encompasses the pharmaceuticals and therapies used to treat this condition. The
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The Male Hypogonadism Market is an emerging segment in the medical industry. This condition affects millions of men around the world and can have serious implications for their physical and mental health. Treatment options are available to help manage symptoms, but often come with associated side effects. The Male Hypogonadism Market is expected to experience significant growth over the coming years as more therapies become available. Pharmaceutical companies are investing
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The male hypogonadism market is a segment of the larger pharmaceutical industry that is focused on developing treatments for male hypogonadism, a condition in which the testes do not produce enough testosterone. In 2022, the male hypogonadism market is expected to continue to grow, driven by the increasing prevalence of the condition and the development of new treatments. The market is expected to be worth billions of dollars in 2022, with strong
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism is a condition in which the body does not produce enough testosterone, the primary male sex hormone. This can lead to a variety of symptoms, including decreased, erectile dysfunction, fatigue, and muscle weakness. Male hypogonadism is typically treated with testosterone replacement therapy (TRT), which can be administered in several forms, such as gels, injections, and pellets. Request For Free Sample Report of "Male Hypogonadism Market"@ https://www.persistencemarketresearch.com/samples/22303 The global male hypogonadism
Male Origin Male Enhancement - Restore Testosterone, Best Reviews, Male Enhancem …
Male Origin Male Enhancement You need to go to your most unmistakable potential in the room, paying little mind to your age. Taking everything into account, you're a man. You ought to be OK at sex. Luckily, Male Origin Male Enhancement Male Enhancement can help with settling any sexual dysfunctions that are holding you down. For example, if you fight with unwinding when you undeniably shouldn't be limp, this can
Libopro Male Enhance Review-Does Libopro Male Enhance Work-Complete Info
LiboPro Male Enhancement to an external site. Herbal is a herbal nutritional supplement that contains a effective mixture of the strongest natural ingredients that help you could Max out your performance. This supplement makes use of a natural composition as a way to assure you the safest results without Side Effects. This is the best quality manner right now to increase your sexual potential and revel in existence the way